MedPath

Explore the Effect of Diet Intervention on Lipid Metabolism and Body Mass Index Among the Patients With Metabolic Syndrome

Not Applicable
Completed
Conditions
Metabolic Syndrome
Registration Number
NCT04475822
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Brief Summary

The prevalence of metabolic syndrome (MetS) is increasing all over the world, which is largely related to the increasing obesity population and the current inactive lifestyle of human beings. It is a common problem facing public health and clinical practice.Metabolic syndrome is an accumulation of biologically metabolic risk factors related to cardiovascular disease and diabetes, including glucose metabolism disorders, hypertension, dyslipidemia, and obesity (especially central obesity).Researchers believe that the common pathological basis of these manifestations is insulin resistance, which is generally considered to be a reduction in the biological effects of insulin compared with the normal biological effects of expected biological phenomena.Nowadays, there are more and more studies on insulin resistance in the world. We have known that age, poor living and eating habits, high blood fat, high blood sugar and stress all lead to insulin resistance.

The researchers hope to reduce weight, reduce body fat rate, improve body fat distribution and insulin resistance, reverse abnormal metabolic indicators, and ultimately reduce the incidence of chronic diseases in patients with metabolic syndrome through the intervention of lifestyle and diet habits in the early stage of the disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
169
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
weightThree months after the intervention

kg

body fatThree months after the intervention
Secondary Outcome Measures
NameTimeMethod
blood pressureThree months after the intervention

mmHg

blood glucoseThree months after the intervention

mmol/L

uric acidThree months after the intervention

µmol/L

blood lipidThree months after the intervention

mmol/L

Trial Locations

Locations (1)

First Affiliated Hospital of Xi an Jiaotong University

🇨🇳

Xi'an, Shaanxi, China

First Affiliated Hospital of Xi an Jiaotong University
🇨🇳Xi'an, Shaanxi, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.